CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population 4-Step Protocol for Disparities in STEMI Care and Outcomes in Women Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative Cardiopulmonary Exercise Testing: What Is its Value? Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock Chronic total occlusion intervention of the non-infarct-related artery in acute myocardial infarction patients: the Korean multicenter chronic total occlusion registry A Test in Context: E/A and E/e' to Assess Diastolic Dysfunction and LV Filling Pressure Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress

JOURNAL: Article Link

​AsiaIntervention正式被PubMed Central收录

admin


AsiaIntervention is the official journal of the Asian Pacific Society of Interventional Cardiology (APSIC) and the Interventional Cardiology Foundation of India (ICFI). Driven by a group of recognised experts worldwide, AsiaIntervention is an international, English language, peer-reviewed journal whose aim is to create a forum of high-quality research and educational articles in the field of percutaneous and surgical cardiovascular interventions with particular emphasis on scientific contributions from the Asia-Pacific region.


亚太地区人口占世界人口的60%以上,在经济高速发展的同时,介入心脏病学发展速度也领先全球。 为进一步满足亚太地区医学界科研成果交流的愿景,着力突出亚太地区学者的科学贡献,在亚太介入心脏病学会(the Asian Pacific Society of Interventional Cardiology, APSIC)与印度介入心脏病基金会(ICFI)的共同努力下,AsiaIntervention这一接收全世界投稿、同行评议、英文版心血管病介入杂志应运而生,其创刊愿景是构建一个由具全球高学术影响力的心血管专家推动的服务于经皮和外科心血管干预领域学术交流和教育的高水平平台。AsiaIntervention编委会成员由来自亚太和欧洲地区知名编辑组成,保障了杂志的专业多元化和独立性。五位总编由来自领域内有声望的副主编和责编协助,我院陈绍良教授荣任副主编。


AsiaIntervention接收文章类型多元,涉及原创研究、临床研究、名家综述、专题报道、评论文章和心脏病学影像等多种形式。发表前由编辑委员会和选中的介入心脏病学的专家评审,同行评审过程为单盲。杂志每年出版两期,包括印刷版和电子版。



自2015年创刊后,AsiaIntervention于近期申请了Science Citation Index® (ISI)、SciVerse Scopus、MEDLINE®/PubMed®索引收录,并于2021年12月17日正式获PubMed Central收录。



点击阅读原文可直接访问AsiaIntervention官方网站在线投稿,陈绍良教授诚邀各位心血管临床和科研工作者积极投稿。